Skip to main content

Find Clinical Trials

Home
Conditions
Central Nervous System Infections

Clinical trial condition

Central Nervous System Infections

Explore clinical trials studying Central Nervous System Infections. Study availability and eligibility vary by location and protocol.

746 public trials 77 recruiting studies

Refine in advanced search Browse all conditions

Central Nervous System Infections trial results

Completed

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine

NCT01309646

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
Locations: GSK Investigational Site Daegu, South Korea

GSK Investigational Site Goyang, South Korea

GSK Investigational Site GyeongSangNam-do, South Korea

GSK Investigational Site Iksan, South Korea

View Trial Details

Completed

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

NCT02096263

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations: GSK Investigational Site Tucson, Arizona, United States

GSK Investigational Site Fayetteville, Arkansas, United States

GSK Investigational Site Anaheim, California, United States

GSK Investigational Site Daly City, California, United States

View all 43 locations

View Trial Details

Completed

Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda

NCT04177485

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +41 more
Locations: Not specified

View Trial Details

Completed

Defining the Immune Response to Nasopharyngeal Colonisation by the Commensal Neisseria Lactamica

NCT03633474

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +7 more
Locations: NIHR Southampton Clinical Research Facility Southampton, United Kingdom

View Trial Details

Completed

Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) Vaccine

NCT00584805

Conditions: Alphavirus Infections, Arbovirus Infections, Brain Diseases, +19 more
Locations: U.S. Army Medical Research Institute of Infectious Diseases Fort Deterick, Maryland, United States

View Trial Details

Completed

Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis

NCT01540838

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bacterial Meningitis, +8 more
Locations: Hospital Pediatrico David Bernardino Luanda, Angola

View Trial Details

Completed

Immunogenicity and Safety Evaluation of Different Sequential Immunization Strategies by Sabin IPV and bOPV in Chinese Infants

NCT03147560

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +11 more
Locations: Chunan Center for Disease Control and Prevention Hangzhou, Zhejiang, China

Longyou Center for Disease Control and Prevention Quzhou, Zhejiang, China

View Trial Details

Completed

A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults

NCT03208101

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations: Korea University Guro Hospital Seoul, South Korea

View Trial Details

Completed

A Clinical Study to Evaluate the Safety and Immunogenicity of Inactivated Poliomyelitis Vaccine in Healthy Infants

NCT03169725

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
Locations: Research Institute for Tropical Medicine Alabang, Philippines

Mahidol University Faculty of Medicine Siriraj Hospital Bangkok, Thailand

Chiang Mai University Maharaj Nakhon Chiang Mai Hospital Chiang Mai, Thailand

View Trial Details

Completed

Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

NCT02422264

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +20 more
Locations: GSK Investigational Site Carlton, Victoria, Australia

GSK Investigational Site Calgary, Alberta, Canada

GSK Investigational Site Halifax, Nova Scotia, Canada

GSK Investigational Site Montreal, Quebec, Canada

View all 30 locations

View Trial Details